Fredun Pharmaceuticals Share Price

    BSE
    820
    +5.90 (0.73%)
    FREDUN • 08 Jul, 2025 | 03:30 PM
    BUY

    1Y Annualised Return

    -0.75%

    3Y Annualised Return

    -2.13%

    5Y Annualised Return

    35.30%

    The current prices are delayed, login or Open Demat Account for live prices.

    Fredun Pharmaceuticals Stock Performance

    1W Return0.99
    1Y Return-2.40
    Today's Low806
    Prev. Close814.10
    Mkt Cap (Cr.)388.78
    1M Return12.96
    3Y Return-2.79
    52-Week High904
    Open806.00
    PE Ratio18.68
    6M Return16.84
    Today's High825
    52-Week Low635
    Face Value10

    Fredun Pharmaceuticals Company background

    Founded in: 1987
    Managing director: Fredun N Medhora
    Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharmas operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , antidiabetics to the latest antiretroviral and anti Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, drysyrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.96, the company came out with a public issue to register its products in the overseas market for exports to partfinance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of companys turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda Sri Lanka.In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.

    As of 08 Jul, 2025, Fredun Pharmaceuticals share price is ₹823.4. The stock opened at ₹806 and had closed at ₹814.1 the previous day. During today’s trading session, Fredun Pharmaceuticals share price moved between ₹806.00 and ₹825.00, with an average price for the day of ₹815.50. Over the last 52 weeks, the stock has recorded a low of ₹635.00 and a high of ₹904.00. In terms of performance, Fredun Pharmaceuticals share price has increased by 16.8% over the past six months and has declined by 0.75% over the last year.

    Read More
    Fredun Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹64,75,592 (-0.38%)

    Daily SIP of 25,000 would have become 64,75,592 in 1 year with a gain of -24,407 (-0.38%)

    View details of Market Depth

    Fredun Pharmaceuticals Fundamental

    Market Cap (in crs)

    388.78

    Face Value

    10

    Turnover (in lacs)

    114.57

    Key Metrics

    Qtr Change %
    29.67% Gain from 52W Low
    23.1
    Dividend yield 1yr %
    Low in industry
    0.1

    Top Mutual Fund Invested in Fredun Pharmaceuticals

    Promoter
    48.9%
    Domestic Institutions
    1.6%
    Public
    49.5%
    Promoter
    48.9%
    Domestic Institutions
    1.6%
    Public
    49.5%
    Promoter
    48.9%
    Domestic Institutions
    1.6%
    Public
    49.5%
    Promoter
    49.2%
    Domestic Institutions
    1.6%
    Public
    49.2%
    Promoter
    49.2%
    Domestic Institutions
    1.6%
    Public
    49.2%
    Promoter
    49.2%
    Domestic Institutions
    1.6%
    Public
    49.2%

    Fredun Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    820
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    816.40
    10Day EMA
    814.40
    12Day EMA
    812.80
    20Day EMA
    803.40
    26Day EMA
    795.30
    50Day EMA
    768.80
    100Day EMA
    744.90
    200Day EMA
    746.20
    5Day SMA
    813.20
    10Day SMA
    816.50
    20Day SMA
    813.10
    30Day SMA
    788.50
    50Day SMA
    756.40
    100Day SMA
    721.50
    150Day SMA
    721.20
    200Day SMA
    725.80
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    6316 Rs
    13914 Rs
    Week Rs
    4327 Rs
    13973 Rs
    Month Rs
    6165 Rs
    15818 Rs
    818.13
    Pivot
    Resistance
    First Resistance
    830.27
    Second Resistance
    837.13
    Third Resistance
    849.27
    Support
    First Support
    811.27
    Second support
    799.13
    Third Support
    792.27
    Relative Strength Index
    60.04
    Money Flow Index
    59.74
    MACD
    17.51
    MACD Signal
    20.92
    Average True Range
    31.37
    Average Directional Index
    20.01
    Rate of Change (21)
    12.96
    Rate of Change (125)
    17.62
    Name
    Holding Percent
    BANK OF INDIA
    1.59

    Fredun Pharmaceuticals Latest News

    03 JUL 2025 | Thursday

    Fredun Pharmaceuticals Ltd - 539730 - Voluntary Disclosure - SEBI Adjudication Order Dated June 30, 2025 (No Penalty Imposed)

    30 JUN 2025 | Monday

    Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

    30 JUN 2025 | Monday

    Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    View More

    Fredun Pharmaceuticals Share Price FAQs

    You can easily buy Fredun Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Fredun Pharmaceuticals share price is ₹904 and ₹635 as of 8/7/2025.

    Please be aware that Fredun Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    66.26
    +0.38 (+0.58%)
    138.20
    -0.34 (-0.25%)
    693.20
    +4.35 (+0.63%)
    2,591.30
    +15.20 (+0.59%)
    166.48
    -0.65 (-0.39%)
    386.50
    -2.95 (-0.76%)
    161.97
    -0.43 (-0.26%)
    263.50
    +4.95 (+1.91%)
    422.00
    +4.90 (+1.17%)
    400.85
    -0.35 (-0.09%)
    Top Gainers
    2,224.50
    +74.70 (+3.47%)
    263.50
    +4.95 (+1.91%)
    2,484.60
    +41.80 (+1.71%)
    343.20
    +5.75 (+1.70%)
    2,820.80
    +41.70 (+1.50%)
    Top Losers
    3,441.30
    -224.80 (-6.13%)
    1,283.80
    -26.70 (-2.04%)
    1,488.30
    -22.20 (-1.47%)
    8,339.50
    -124.00 (-1.47%)
    5,440.00
    -59.00 (-1.07%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -